All Viruses articles – Page 35
-
NewsSpecial insecticide paint may help curb zika and dengue fever outbreaks
Scientists showed that insecticide paint could effectively decrease mosquito presence in Cabo Verde (Cape Verde) for up to one year, making this paint a potential strategy to decrease the transmission of vector-borne diseases.
-
NewsMicrobial viruses act as secret drivers of climate change
In a new study, scientists have discovered that viruses that infect microbes contribute to climate change by playing a key role in cycling methane, a potent greenhouse gas, through the environment.
-
NewsResearchers uncover how virus causes cancer, point to potential treatment
Kaposi sarcoma-associated herpesvirus activates a specific pathway to drive viral persistent infection and cell growth, paving the way for tumors to form.
-
NewsNew antibodies target “dark side” of influenza virus protein
Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored “dark side” of the neuraminidase (NA) protein head.
-
NewsThe future is personalised care for influenza and flu-like illness
A new research review will focus on a future of more personalised care for diseases such as influenza, so that patients and doctors will be able to more accurately determine when the infectious part of the illness has passed.
-
NewsResearchers reveal how the SARS-CoV-2 virus acquires its spherical shape
Researchers report that when the M protein, which is adjacent to the spike protein on SARS-CoV-2, gets lodged in the membrane, it coaxes the membrane to curve by locally reducing the membrane thickness.
-
NewsVaping can increase susceptibility to infection by SARS-CoV-2
Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a new study has found.
-
NewsBCG mechanism extends protection to beat influenza A
A new study uncovered a previously unknown mechanism that extends the BCG vaccine’s shield to combat influenza A virus—the most prevalent flu strain.
-
NewsFusion protein reveals a conservative antigenic domain across herpesviruses
A new study proposes that the gB DII domain within the herpesvirus family constitutes a broadly conserved neutralizing epitope structural domain.
-
NewsSpace-grown antiviral drug successfully brought back to earth in private Varda Space capsule
Space-grown crystals of an antiviral drug have been brought to earth following the successful recovery of the capsule from Varda Space Industries’ W-1 mission.
-
News‘Dynamic duo’ defences in bacteria ward off viral threats
Scientists have discovered that bacteria can pair up their defence systems to create a formidable force, greater than the sum of its parts, to fight off attack from phage viruses.
-
FeaturesUnder the microscope: Alaskapox
Alaskapox virus (AKPV) is genetically more similar to old world than new world Orthopoxvirus.
-
NewsComplement system response to AAV vector gene therapy
Recent clinical trials utilizing high doses of adeno-associated virus (AAV) vectors have highlighted a new challenge to AAV gene transfer – activation of the complement system.
-
NewsStudy examines medical mystery of child hepatitis outbreak
A study into an unexpected wave of severe hepatitis cases in 2022 supports the theory that it was caused by an infection of different viruses at the same time, but also reveals cases were higher and more severe than initially thought.
-
NewsStudy of usefulness of lockdowns during epidemics identifies alternate solution
Researchers found that small nonpharmaceutical interventions can tip the optimal response between very different approaches to slowing viral spread and identified an alternate approach that has previously not been recognized as effective.
-
NewsLong-acting HIV treatment demonstrates efficacy in people with challenges taking daily medicine as prescribed
Long-acting antiretroviral therapy (ART) with cabotegravir and rilpivirine was superior in suppressing HIV replication compared to daily oral ART in people who had been unable to maintain viral suppression through an oral daily regimen, according to interim data from a randomized trial. Source: NIAID Colorized transmission electron micrograph ...
-
NewsScientists craft enhanced viral structure in VLP vaccines through polymer restructuring
Researchers reported a viromimetic polymer nanoparticle vaccine (VPNVax), crafted by rearranging the RBD proteins of the coronavirus and modifying them onto the surface of pre-assembled polyethylene glycol-polylactic acid polymer nanoparticles.
-
NewsBat mating swarms may be the key to solving the next pandemic
The evolution of viral tolerance in Myotis bats may help scientists prevent future pandemics, say researchers.
-
NewsDroughts may trigger HIV transmission increase among women in rural sub-Saharan Africa
Droughts have the potential to increase the spread of HIV for women living in rural parts of Africa, researchers at the University of Bristol have found.
-
NewsPD-1-enhanced DNA vaccine achieves 6-year cART-free AIDS prevention and virologic control
Researchers have found that PD-1-enhanced DNA vaccination can induce sustained virus-specific CD8+ T cell immunity in an AIDS monkey model.